Results 41 to 50 of about 5,158 (243)

Characteristics and management of headache among psychiatric outpatients at a Japanese general hospital: A retrospective study with an exploratory CGRP case series

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 4, Issue 4, December 2025.
Abstract Aim Headache is one of the most frequent somatic complaints in psychiatric practice and is often attributed to underlying mental disorders. However, primary headache disorders—particularly migraine and tension‐type headache (TTH)—commonly coexist with psychiatric conditions.
Kyohei Otani   +2 more
wiley   +1 more source

Does the Addition of Ginger Decrease Migraine Pain? [PDF]

open access: yes, 2020
OBJECTIVE: The objective of this selective EBM review is to determine whether or not “does the addition of ginger decrease migraine pain”. STUDY DESIGN: A systematic review of three peer-reviewed studies published between the years of 2011-2018.
Nguyen, Stephanie
core   +1 more source

The Concise Guide to PHARMACOLOGY 2025/26: G protein‐coupled receptors

open access: yesBritish Journal of Pharmacology, Volume 182, Issue S1, Page S24-S151, December 2025.
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander   +206 more
wiley   +1 more source

Drug‐Induced Acrocyanosis: Highlighting Venlafaxine as a Potential Culprit

open access: yesClinical Case Reports, Volume 13, Issue 11, November 2025.
Resolution of venlafaxine‐induced acral cyanosis following discontinuation of the drug. ABSTRACT Acrocyanosis is a peripheral vascular disorder characterized by bluish discoloration of the distal extremities. While drug‐induced acrocyanosis has been associated with selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and other ...
Sujita Manandhar   +3 more
wiley   +1 more source

Is Vitamin D an Effective Add-on Therapy for Decreasing Migraine Frequency in Adults? [PDF]

open access: yes, 2023
Objective: The objective of this selective EBM review is to determine “Is Vitamin D an effective add-on Therapy for Decreasing Migraine Frequency in Adults” Study Design: A review of two randomized controlled trials and a placebo-controlled double-blind ...
Conway, Jazmin
core   +1 more source

Clinical Practice Guideline for Headache Disorders 2021

open access: yesNeurology and Clinical Neuroscience, Volume 13, Issue 6, Page 389-407, November 2025.
ABSTRACT The International Headache Society published the International Classification of Headache Disorders, 3rd edition in 2018. In this classification, Chapter 3—previously “Cluster headache and other trigeminal‐autonomic cephalalgias”—was renamed “Trigeminal‐autonomic cephalalgias (TACs).” Trigeminal‐autonomic cephalalgias are a group of disorders ...
Nobuo Araki   +10 more
wiley   +1 more source

Analgesic usage behaviours of patients with migraine [PDF]

open access: yes, 2018
Objective: The objective of this research was to determine analgesic usage behaviors of patients with migraine. Method: In this descriptive and cross-sectional type research,105 patients who applied to neurology polyclinic in a public hospital between ...
Karakoç Kumsar, Azime   +2 more
core  

Does erenumab reduce monthly migraine frequency from baseline in adults with episodic migraines? [PDF]

open access: yes, 2023
OBJECTIVE: The objective of this selective EBM review is to determine “Does erenumab reduce monthly migraine frequency from baseline in adults with episodic migraines?” STUDY DESIGN: An EBM review of three double blind, RCTs (randomized control trials ...
Pitman, Rachel M.
core   +1 more source

Genetic Basis of the Negative Response to the Use of Triptans for the Treatment of Migraine—A Systematic Review and Meta‐Analysis

open access: yesBrain and Behavior, Volume 15, Issue 10, October 2025.
To systematize the genetic basis correctly associated with nonresponse to triptan, we revised etiological studies on Web of Science, Embase, and PubMed until 2023. We found that only polymorphisms in the SLC6A4, 5‐HT1B, and COMT genes have a stronger association with this condition. More robust studies are needed to increase this certainty.
Victoria Gomes Andreata   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy